Multiple myeloma: open trials in India

• NCT05519085

  A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

  Trial Treatment · Phase 3 · Celgene

  HCG Aastha Cancer Centre, Ahmedabad · KLES Dr. Prabhakar Kore Hospital & M.R.C, Belagavi · Marengo Asia Hospitals Gurugram, Gurugram · Christian Medical College & Hospital, Ludhiana · Madurai · Mumbai Oncocare Centre - Nanachowk, Mumbai · Jawaharlal Institute of postgraduate medical education and research, Puducherry · Varanasi

  Registry updated 2026-10-30

• NCT07891923

  Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple Myeloma

  Trial Treatment · Phase 2 · Tata Memorial Centre

  Dr.Sumeet Mirgh, Navi Mumbai · Actrec Tmc, Navi Mumbai

  Registry updated 2026-10-27

• NCT07518186

  A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  M S Ramaiah Medical College and Hospital, Bengaluru · Fortis Memorial Research Institute, Gūrgaon · Bhagwan Mahaveer Cancer Hospital & Research Centre, Jaipur · Nil Ratan Sircar Medical College and Hospital, Kolkata · Tata Medical Center, Kolkata · Rajiv Gandhi Cancer Institute And Research Centre, New Delhi · Deenanath Mangeshkar Hospital and Research Centre, Pune

  Registry updated 2026-09-25

• NCT06679101

  A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

  Trial Treatment · Phase 3 · GlaxoSmithKline

  Ahmedabad · Bangalore · Hyderabad · Kolkata · Pune · Sushrut Hospital and Research

  Registry updated 2026-04-22

• NCT05862012

  Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

  Trial Treatment · Phase 1 · Ichnos Sciences SA

  HCG Hospital, Bangalore · Health Care Global Enterprises Ltd., Bangalore · Apollo Hospital International Limited, Gandhinagar · Apollo Cancer Centers, Hyderabad · Deenanath Mangeshkar Hospital and Research Centre, Pune

  Registry updated 2026-04-01

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error